Literature DB >> 7657397

Methadone maintenance and the likelihood of risky needle-sharing.

J R Caplehorn1, M W Ross.   

Abstract

Survey data were used to study the association of methadone maintenance and needle-sharing. An ordinal scale of HIV risk was derived from the number of persons from whom subjects reported accepting a used needle and syringe in the 6 months prior to interview. The odds of respondents in methadone maintenance being in the higher risk group were half those of daily heroin users not in treatment for all three transitions in a four-level ordinal scale of risk (OR 0.55, 95% CL 0.33 to 0.90, ordinal logistic regression). This association disappeared when methadone patients who had not injected in the month prior to interview were excluded from the analysis. Subjects' knowledge concerning HIV and AIDS had no measurable association with the outcome. It is concluded that methadone maintenance reduces heroin addicts' risk of infection with HIV by reducing the likelihood of their injecting drugs rather than by changing their injecting behavior.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657397     DOI: 10.3109/10826089509048753

Source DB:  PubMed          Journal:  Int J Addict        ISSN: 0020-773X


  16 in total

1.  HIV transmission and the cost-effectiveness of methadone maintenance.

Authors:  G S Zaric; P G Barnett; M L Brandeau
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

Review 2.  HIV prevention among injection drug users: the need for integrated models.

Authors:  David S Metzger; Helen Navaline
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

3.  Attitudes and practices regarding the use of methadone in US state and federal prisons.

Authors:  Josiah D Rich; Amy E Boutwell; David C Shield; R Garrett Key; Michelle McKenzie; Jennifer G Clarke; Peter D Friedmann
Journal:  J Urban Health       Date:  2005-05-25       Impact factor: 3.671

Review 4.  Drug treatment as HIV prevention: a research update.

Authors:  David S Metzger; George E Woody; Charles P O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

5.  HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.

Authors:  George E Woody; Douglas Bruce; P Todd Korthuis; Sumedha Chhatre; Sabrina Poole; Maureen Hillhouse; Petra Jacobs; James Sorensen; Andrew J Saxon; David Metzger; Walter Ling
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

6.  The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trial.

Authors:  August F Holtyn; Mikhail N Koffarnus; Anthony DeFulio; Sigurdur O Sigurdsson; Eric C Strain; Robert P Schwartz; Jeannie-Marie S Leoutsakos; Kenneth Silverman
Journal:  Prev Med       Date:  2014-03-04       Impact factor: 4.018

7.  Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area.

Authors:  H Thiede; H Hagan; C S Murrill
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

8.  Incidence of HIV among injection drug users entering drug treatment programs in four US cities.

Authors:  C S Murrill; D R Prevots; M S Miller; L A Linley; J E Royalty; M Gwinn
Journal:  J Urban Health       Date:  2001-03       Impact factor: 3.671

Review 9.  Drug abuse treatment as AIDS prevention.

Authors:  D S Metzger; H Navaline; G E Woody
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Overcoming obstacles to implementing methadone maintenance therapy for prisoners: implications for policy and practice.

Authors:  Michelle McKenzie; Amy Nunn; Nickolas D Zaller; Alexander R Bazazi; Josiah D Rich
Journal:  J Opioid Manag       Date:  2009 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.